No one can pick the bottom, but if this company was simply the North Carolina plant, with its 15% year on year growth, we would be high fiving each other. Nextstellis maybe 8 months away, and the company has hung its hat on this sales-wise ( a novel natural contraceptive is clearly unique!). Plus Myring might be -3 months away (complex product but widely approved in Europe including very recently in Holland) also sales-wise a significant product, particularly because its approval would signal that Nextstellis (another Mithra product) would be treated with favour ( or at least no suspicion) by FDA. Honestly, FDA acceptance of the Nextstellis filing means I believe acceptance is a matter of process and time.
The company has plenty of faults by reference to its capital destroying past, but look on the bright side, we are in a new era, and in a few years this stock will be back! Don’t give up at the bottom.
MYX Price at posting:
36.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)